35 studies found for:
Behcet's Disease
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Recruiting |
Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions
|
||||
| 2 | Terminated |
Stem Cell Transplantation in Ocular Lesions of Behcet's Disease
|
||||
| 3 | Completed |
Phase III Study in Refractory Behcet's Disease
|
||||
| 4 | Recruiting |
Anakinra for Behcet's Disease
|
||||
| 5 | Recruiting |
Etanercept: Single Blind Control Study in Ocular Manifestations of Behcet's Disease
|
||||
| 6 | Unknown † |
Flucinolone Acetonide Implant for Treating Refractory Ocular Behcet's Disease
|
||||
| 7 | Completed |
Psychological Symptoms in Patients With Behcet's Disease by SCL90-R
|
||||
| 8 | Completed |
Behçet's Disease and Eosinophil Cationic Protein
|
||||
| 9 |
Active, not recruiting
Has Results |
A Study of Adalimumab in Japanese Subjects With Intestinal Behçet's Disease
|
||||
| 10 | Unknown † |
Interferon-alpha2a Versus Cyclosporin A for Severe Ocular Behcet`s Disease (INCYTOB)
|
||||
| 11 | Completed |
MEVALONATE KINASE GENE MUTATIONS AND THEIR CLINICAL CORRELATIONS IN BEHÇET'S DISEASE
|
||||
| 12 | Completed |
Colchicine Randomized Double-Blind Controlled Crossover Study in Behcet's Disease
|
||||
| 13 |
Completed
Has Results |
Low Dose Interferon Alpha Treatment for Oral Ulcers of Behcet's Disease
|
||||
| 14 | Recruiting |
Immunogenetic Mechanisms in Behcet's Disease
|
||||
| 15 | Withdrawn |
A Pilot Study of XOMA 052 in Familial Cold Autoinflammatory Syndrome / Muckle-Wells Syndrome and Behcet's Disease
|
||||
| 16 | Completed |
HAT in Eye Complications of Behcet's Disease
|
||||
| 17 | Unknown † |
The Efficacy of Methylprednisolone in the Treatment of Patients With Ocular Involvement in Behcet's Disease
|
||||
| 18 | Completed |
Rituximab for the Treatment of Severe Ocular Manifestations of Behcet's Disease
|
||||
| 19 | Completed |
The Relationship Between Serum Levels of Angiogenin, bFGF, VEGF and Ocular Involvement in Patients With Behçet's Disease
|
||||
| 20 | Recruiting |
Tocilizumab for the Treatment of Behcet's Syndrome
|
† Indicates status has not been verified in more than two years
